相关实验视频

Updated: May 1, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

肺微生物组在固定气流阻塞的支气管切除症中的临床影响:一项前性队列研究

Yen-Fu Chen^1,2,3, Hsin-Han Hou⁴, Ning Chien⁵

¹Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin County, Taiwan.

Respiratory research

|August 14, 2024

概括

支气管炎中固定气流阻塞 (FAO) 与独特的肺微生物组和炎症增加有关,特别是在Pseudomonas aeruginosa. 这表明独特的疾病内型会影响严重程度和恶化.

科学领域:

肺部医学肺部医学
微生物学微生物学
遗传学是一个遗传学.

背景情况:

空气流阻塞是支气管切除症严重程度和预后的一个关键指标.
肺部微生物群,炎症和支气管切除与固定气流阻塞 (FAO) 的结果之间的相互作用尚未得到充分理解.
这项研究调查了在有或没有FAO的支气管切除症患者中的这些相互作用,并将其与慢性阻塞性肺病 (COPD) 患者进行比较.

研究的目的:

探索肺部微生物群,呼吸道炎症和支气管切除症患者的临床结果之间的关系,有或没有固定气流阻塞 (FAO).
将这些相互作用与在被诊断为慢性阻塞性肺病 (COPD) 的患者中观察到的相互作用进行比较.
根据临床和微生物概况,与粮农组织在支气管切除症中识别潜在的独特内型.

主要方法:

一项在台湾进行的前性观察性研究,涉及有支气管切除或COPD的患者.
支气管洗 (BAL) 样本用于16SrRNA基因测序,以分析肺微生物组合.
评估了炎症标志物,并使用螺旋测量来确认固定气流阻塞 (FAO). 该队列包括181名患者:86名患有慢性肺炎,46名患有支气管切除症,49名患有支气管切除症和FAO.

主要成果:

支气管切除症患者 (有或没有FAO) 呈现出阿尔法多样性的减少和蛋白质细菌的占主导地位,与COPD患者显著不同.
与没有粮农组织的COPD和支气管病变相比,FAO的支气管病变显示出更严重的疾病和更高的恶化风险.
Pseudomonas aeruginosa 的存在与增加的中性友炎 (IL-1β,IL-8,TNF-α) 和更高的支气管切除症严重程度相关,可能会增加恶化风险. 罗斯标准确定了与粮农组织组织合作的支气管切除症内不同的内型.

结论:

患有FAO的支气管切除症患者可能呈现出两种不同的内型,其特点是疾病严重程度更高,并且微生物群的特征更接近没有FAO的支气管切除症,而不是COPD.
Pseudomonas aeruginosa,中性友炎症和疾病严重程度之间的相关性突出显示了FAO与支气管病变中的微生物模式的临床重要性.
这些微生物模式可能在支气管病变的进展和恶化中发挥作用.

关键词:

支气管切除症是一种支气管切除症.支气管气管洗是一种支气管气管洗.慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.固定的空气流阻碍障碍物肺部的微生物群.中性侵性炎症是一种中性侵性炎症.罗斯标准 (ROSE标准) 是一个标准.

更多相关视频

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Atelectasis II: Pathophysiology

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...